Literature DB >> 29444224

A systematic review with meta-analysis of the prevalence of gastroesophageal reflux in congenital diaphragmatic hernia pediatric survivors.

J V Arcos-Machancoses1, C Ruiz Hernández1, J Martin de Carpi1, S Pinillos Pisón1.   

Abstract

Congenital diaphragmatic hernia survivors are a well-known group at risk for developing gastroesophageal reflux disease that may be particularly long-term severe. The aim of this study is to provide a systematic review of the prevalence of gastroesophageal reflux in infant and children survivors treated for congenital diaphragmatic hernia.Electronic and manual searches were performed with keywords related to congenital diaphragmatic hernia, gastroesophageal reflux disease, and epidemiology terms. Summary estimates of the prevalence were calculated. Effect model was chosen depending on heterogeneity (I2). Factors potentially related with the prevalence, including study quality or the diagnostic strategy followed, were assessed by subgroup and meta-regression analyses. Risk of publication bias was studied by funnel plot analysis and the Egger test.The search yielded 140 articles, 26 of which were included in the analyses and provided 34 estimates of prevalence: 21 in patients aged 12 months or younger, and 13 in older children. The overall prevalence of gastroesophageal reflux disease in infants was 52.7% (95% confidence interval [CI]: 43.2% to 62.1%, I2 = 88.7%) and, in children over 1 year old, 35.1% (95% CI: 25.4% to 45.3%, I2 = 73.5%). Significant clinical and statistical heterogeneity was found. The strategy chosen for gastroesophageal reflux diagnosis influenced the reported prevalence. The only estimate obtained with a systematic use of multichannel intraluminal impedance provided a higher prevalence in both age groups: 83.3% (95% CI: 67.2% to 93.6%) and 61.1% (95% CI: 43.5% to 76.9%) respectively. This last prevalence did not significantly differ from that obtained using only low risk of bias estimates.As a conclusion, gastroesophageal reflux disease is commonly observed after congenital diaphragmatic hernia repair and is almost constantly present in the first months of life. It may be underdiagnosed if systematically esophageal monitoring is not performed. This should be considered when proposing follow-up and management protocols for congenital diaphragmatic hernia survivors.

Entities:  

Mesh:

Year:  2018        PMID: 29444224     DOI: 10.1093/dote/dox158

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  5 in total

1.  Long-Term Outcomes of Congenital Diaphragmatic Hernia: Report of a Multicenter Study in Japan.

Authors:  Masaya Yamoto; Kouji Nagata; Keita Terui; Masahiro Hayakawa; Hiroomi Okuyama; Shoichiro Amari; Akiko Yokoi; Kouji Masumoto; Tadaharu Okazaki; Noboru Inamura; Katsuaki Toyoshima; Yuhki Koike; Yuta Yazaki; Taizo Furukawa; Noriaki Usui
Journal:  Children (Basel)       Date:  2022-06-08

Review 2.  Gastroesophageal reflux in children: an updated review.

Authors:  Alexander Kc Leung; Kam Lun Hon
Journal:  Drugs Context       Date:  2019-06-17

3.  Long-term feeding issue and its impact on the daily life of congenital diaphragmatic hernia survivors: results of the first patient-led survey.

Authors:  Beverley Power; Soichi Shibuya; Brenda Lane; Simon Eaton; Paolo De Coppi
Journal:  Pediatr Surg Int       Date:  2019-11-06       Impact factor: 1.827

4.  Long-Term Evaluation of Gastroesophageal Reflux in Neonates with and without Preventive Anti-reflux Surgery at the Time of Congenital Diaphragmatic Hernia Repair.

Authors:  Christoph von Schrottenberg; Susanne Deeg; Christel Weiss; Rüdiger Adam; Lucas M Wessel; Michael Boettcher; Katrin B Zahn
Journal:  Children (Basel)       Date:  2022-07-29

5.  Distress and post-traumatic stress in parents of patients with congenital gastrointestinal malformations: a cross-sectional cohort study.

Authors:  D Roorda; A F W van der Steeg; M van Dijk; J P M Derikx; R R Gorter; J Rotteveel; J B van Goudoever; L W E van Heurn; J Oosterlaan; L Haverman
Journal:  Orphanet J Rare Dis       Date:  2022-09-11       Impact factor: 4.303

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.